Status:

COMPLETED

Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy

Lead Sponsor:

University of Mississippi Medical Center

Conditions:

Pregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia)

Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe)

Eligibility:

FEMALE

18-45 years

Brief Summary

The utilization of external cardiohemodynamic patient assessment, applying non-invasive stick-on contact patches to the mother's neck on either side and chest wall on either side, enables the practiti...

Detailed Description

Pregnant patients with severe acute hypertension due either to superimposed preeclampsia, severe preeclampsia or severe gestational hypertension will be randomized to receive either of two antihyperte...

Eligibility Criteria

Inclusion

  • Nulliparous or parous patients with severe hypertension
  • Singleton gestation
  • Gestational age greater than 20 weeks

Exclusion

  • Multiple gestation
  • Gestational age less than 20 weeks

Key Trial Info

Start Date :

December 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01248169

Start Date

December 1 2009

End Date

November 1 2013

Last Update

December 12 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wiser Hospital for Women and Infants at the University of Mississippi Medical Center

Jackson, Mississippi, United States, 39216

Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy | DecenTrialz